James Kauderer

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

16h-index1.8kcitations29works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endometrial and Cervical Cancer Treatments(13), Ovarian cancer diagnosis and treatment(11), Lymphatic System and Diseases(6), Cervical Cancer and HPV Research(4), Endometriosis Research and Treatment(4)

Publications29 total

Patient and physician factors associated with participation in cervical and uterine cancer trials: An NRG/GOG247 study
UNC Libraries·2020Open Access
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function
Gynecologic Oncology·2020· 66 citedOpen Access
GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients
Gynecologic Oncology·2019· 123 citedOpen Access
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)
Gynecologic Oncology·2019· 53 citedOpen Access
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study
Cancer Prevention Research·2019· 9 citedOpen Access
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study
Gynecologic Oncology·2018· 110 cited
GOG 244, The lymphedema and gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lower extremity lymphedema
Gynecologic Oncology·2018
GOG 244, the lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients
Gynecologic Oncology·2018· 10 cited
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study
Gynecologic Oncology·2018· 29 citedOpen Access
Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study
Menopause The Journal of The North American Menopause Society·2016· 33 citedOpen Access
Patient and physician factors associated with participation in cervical and uterine cancer trials: An NRG/GOG247 study
Gynecologic Oncology·2015· 22 citedOpen Access
Correlation between surgeon's assessment of residual disease and findings on postoperative pre-treatment computed tomography scan in women with advanced stage ovarian cancer reported to have undergone optimal cytoreduction: An NRG Oncology/GOG study
Gynecologic Oncology·2015· 1 cited
Factors Associated With Grade 3 or 4 Treatment-RelatedToxicity in Women With Advanced or RecurrentCervical Cancer
International Journal of Gynecological Cancer·2014· 8 citedOpen Access
A fast Monte Carlo expectation–maximization algorithm for estimation in latent class model analysis with an application to assess diagnostic accuracy for cervical neoplasia in women with atypical glandular cells
Journal of Applied Statistics·2013· 4 citedOpen Access
Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study
British Journal of Cancer·2013· 21 citedOpen Access
A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study
Cancer Causes & Control·2012· 5 cited
Abstract 4614: Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study
Cancer Research·2012
Factors associated with grade 3–4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of Gynecologic Oncology Group trials (GOG) 179 and 204
Gynecologic Oncology·2012· 1 cited
Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study
Gynecologic Oncology·2011· 5 citedOpen Access
Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study
British Journal of Cancer·2010· 14 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Joan L. Walker(11), David S. Alberts(10), Lari Wenzel(7), John P. Curtin(6), Oliver Zivanovic(6), Jay W. Carlson(5), Albert J. Bonebrake(5), John T. Soper(5), Cara Mathews(5), Kathleen M. Darcy(5), Cornelia L. Trimble(4), Richard J. Zaino(4), Peter Lim(4), Alan D. Hutson(4), Linda Van Le(4), William H. Rodgers(4), Eric J. Stanbridge(4), Steven M. Silverberg(3), Jeanne Carter(3), Jane M. Armer(3)